Work

Curative Potential of Axicabtagene Ciloleucel (Axi-Cel): An Exploratory Long-Term Survival Assessment in Patients with Refractory Large B-Cell Lymphoma from ZUMA-1

Year: 2023

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2023-174288

Authors: Sattva S. Neelapu, Caron A. Jacobson, Armin Ghobadi, David B. Miklos, Lazaros J. Lekakis, Clare Spooner, Jenny J. Kim, Harry Miao, Allen Xiaodong Xue, Yan Zheng, Frederick L. Locke

Institutions: The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, Washington University in St. Louis, Stanford University, University of Miami Health System, Sylvester Comprehensive Cancer Center, Moffitt Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389259256

Cites:

Cited by: 5

Related to: 10